XML 21 R8.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Accumulated Other Comprehensive (Loss) Income
Treasury Stock
Non- controlling Interests
Balance, beginning of period at Dec. 31, 2020 $ 2,453.6 $ 1.2 $ 3,402.5 $ 3,388.8 $ (397.3) $ (3,954.2) $ 12.6
Balance, beginning of period (in shares) at Dec. 31, 2020   117,555,991          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 382.4     382.4      
Other comprehensive income (loss) 7.9       7.9    
Issuances under equity plans 0.2   5.4     (5.2)  
Issuances under equity plans (in shares)   206,074          
Share-based compensation expense 36.8   36.8        
Dividends (136.6)     (136.6)      
Repurchases of common stock (210.0)         (210.0)  
Noncontrolling interest transactions (2.6)           (2.6)
Balance, end of period at Dec. 31, 2021 2,531.7 $ 1.2 3,444.7 3,634.6 (389.4) (4,169.4) 10.0
Balance, end of period (in shares) at Dec. 31, 2021   117,762,065          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 373.8     373.8      
Other comprehensive income (loss) (69.3)       (69.3)    
Issuances under equity plans (8.2)   0.3     (8.5)  
Issuances under equity plans (in shares)   265,944          
Share-based compensation expense 37.6   37.6        
Dividends (139.9)     (139.9)      
Repurchases of common stock (270.0)         (270.0)  
Noncontrolling interest transactions 2.4   1.6       0.8
Balance, end of period at Dec. 31, 2022 2,458.1 $ 1.2 3,484.2 3,868.5 (458.7) (4,447.9) 10.8
Balance, end of period (in shares) at Dec. 31, 2022   118,028,009          
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net earnings 88.8     88.8      
Other comprehensive income (loss) (7.3)       (7.3)    
Issuances under equity plans (8.4)   2.0     (10.4)  
Issuances under equity plans (in shares)   359,632          
Share-based compensation expense 28.7   28.7        
Dividends (144.3)     (144.3)      
Repurchases of common stock (181.5)         (181.5)  
Balance, end of period at Dec. 31, 2023 $ 2,234.1 $ 1.2 $ 3,514.9 $ 3,813.0 $ (466.0) $ (4,639.8) $ 10.8
Balance, end of period (in shares) at Dec. 31, 2023   118,387,641